Brighten: And are there things that are being missed
The SELECT trial, published in 2024, showed that semaglutide reduced major adverse cardiovascular events (MACE: heart attack, stroke, cardiovascular death) by 20% in individuals with obesity, even independent of weight loss magnitude. Why
The color-coded system simplifies needle gauge identification, warranting accuracy and ease during clinical procedures while maintaining high standards of sterility and reliability
Perhaps, I thought, there were nuances that Id missed
Instead, they will start the medication from the starting dose and titrate it gradually
If you want a deeper look at how this mechanism affects bowel function, our guide on why GLP-1 medications cause constipation offers a helpful breakdown